MS news

Source Radio Times: Documentary following leading lawyer Mark Lewis, the man who fought the News of the World in the phone hacking scandal, as he joins a clinical trial that might offer a breakthrough cure for multiple sclerosis. He learned he had the condition at the age of 25 but his high-profile battle with the […]

Source Multiple Sclerosis News Today: Celgene released the results of two Phase 3 trials showing that patients with relapsing multiple sclerosis (MS) who were treated with ozanimod had lower relapse rates and fewer MRI brain lesions compared to those given a current first-line therapy, Avonex (interferon β-1a). These results will be used to support a request for ozanimod’s approval as an MS therapy

Source Mutiple Sclerosis News Today: In the future, a blood test may make diagnosing multiple sclerosis (MS) much easier, thanks to newly identified biomarker patterns that distinguish between MS patients and healthy people.

Source MS Society: A new oral treatment for relapsing MS, called cladribine, will be made available on the NHS in England and Wales within the next three months.

Source Multiple Sclerosis News Today: A blood-clotting protein called fibrinogen prevents myelin production and blocks the neuron remyelination repair process in mice, a study finds.  

Source MS Society: Researchers in the US have proclaimed their initial test of ibudilast for MS a success.

Source Labiotech.eu BC Platforms and Microsoft will be working with Biogen and the Accelerated Cure Project to study the genetics of multiple sclerosis and accelerate research.